Eur Rev Med Pharmacol Sci 2020; 24 (22): 11982-11984
DOI: 10.26355/eurrev_202011_23861

Editorial – Role of Highly Active Antiretroviral Therapy (HAART) for the COVID-19 treatment

B.M. Nastri, C. Zannella, V. Folliero, L. Rinaldi, L. Restivo, D. Stelitano, R. Sperlongano, L.E. Adinolfi, G. Franci

Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, Naples, Italy. gfranci@unisa.it

Free PDF Download

To cite this article

B.M. Nastri, C. Zannella, V. Folliero, L. Rinaldi, L. Restivo, D. Stelitano, R. Sperlongano, L.E. Adinolfi, G. Franci
Editorial – Role of Highly Active Antiretroviral Therapy (HAART) for the COVID-19 treatment

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 22
Pages: 11982-11984
DOI: 10.26355/eurrev_202011_23861

Keywords Related articles:

  1. Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study
  2. HIV/AIDS patient’s satisfactory and their expectations with pharmacy service at specialist antiretroviral therapy (ART) units
  3. Potential mechanisms by which the oxygen-ozone (O2-O3) therapy could contribute to the treatment against the coronavirus COVID-19
  4. The dual role of anti-viral therapy in the treatment of Coronavirus disease 2019
  5. Editorial – COVID-19, more than a viral pneumonia